TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Presented preliminary Phase 1 clinical data from heme malignancies trial at the ASGCT 26th Annual…
Presented preliminary Phase 1 clinical data from heme malignancies trial at the ASGCT 26th Annual…
Presented preliminary Phase 1 clinical data from heme malignancies trial at the ASGCT 26th Annual…
Camsirubicin Phase 1b Trial Currently at 5th Dose-Level (650 mg/m2), Generating Encouraging ResultsMNPR-101 Radiopharma Program…
Camsirubicin Phase 1b Trial Currently at 5th Dose-Level (650 mg/m2), Generating Encouraging ResultsMNPR-101 Radiopharma Program…
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR…
Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007…
Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
AFM13 combination with AB-101 NK cells (LuminICE-203): On track to report initial efficacy and safety…
AFM13 combination with AB-101 NK cells (LuminICE-203): On track to report initial efficacy and safety…
Versa Recognized in Hype Cycle for Zero Trust Networking, 2023 Report; Company also Listed as…
Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform EDINBURGH, Scotland, Aug. 10, 2023…
Vancouver, British Columbia–(Newsfile Corp. – August 10, 2023) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
With positive operating cash flow for Q2 and YTD, and four consecutive quarters of record…
New line of consumer-centric phones, awarded by two tier-one carriers in North America, addresses market…
New York, Aug 10, 2023 – (ACN Newswire) – Society Pass Incorporated (Nasdaq: SOPA) (“SoPa”),…